91制片厂

Search

Did you mean
compact elevator
Your search for "compact elevators" gave back 87 results.

Gallbladder Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Gallbladder Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's...
颁补迟补濒辞驳:听
Drug Pipeline
Global Markets Direct
Global
October 2022
Price: USD 2,000.00

Fabry Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Fabry Disease Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct's...
颁补迟补濒辞驳:听
Drug Pipeline
Global Markets Direct
Global
April 2022
Price: USD 2,000.00

Peroxisome Proliferator Activated Receptor Delta - Pipeline Review, H2 2019

Peroxisome Proliferator Activated Receptor Delta - Pipeline Review, H2 2019 Summary Peroxisome Proliferator Activated Receptor Delta (NUCI or Nuclear...
颁补迟补濒辞驳:听
Drug Pipeline
Global Markets Direct
Global
August 2019
Price: USD 3,500.00

Peroxisome Proliferator Activated Receptor Delta (NUCI or Nuclear Hormone Receptor 1 or Nuclear Receptor Subfamily 1 Group C Member 2 or Peroxisome Proliferator Activated Receptor Beta or NR1C2 or PPARD) - Pipeline Review, H1 2019

Peroxisome Proliferator Activated Receptor Delta (NUCI or Nuclear Hormone Receptor 1 or Nuclear Receptor Subfamily 1 Group C Member 2 or Peroxisome...
颁补迟补濒辞驳:听
Drug Pipeline
Global Markets Direct
Global
March 2019
Price: USD 3,500.00

Peroxisome Proliferator Activated Receptor Delta (NUCI or Nuclear Hormone Receptor 1 or Nuclear Receptor Subfamily 1 Group C Member 2 or Peroxisome Proliferator Activated Receptor Beta or NR1C2 or PPARD) - Pipeline Review, H2 2018

Peroxisome Proliferator Activated Receptor Delta (NUCI or Nuclear Hormone Receptor 1 or Nuclear Receptor Subfamily 1 Group C Member 2 or Peroxisome...
颁补迟补濒辞驳:听
Drug Pipeline
Global Markets Direct
Global
July 2018
Price: USD 3,500.00

Peroxisome Proliferator Activated Receptor Delta (NUCI or Nuclear Hormone Receptor 1 or Nuclear Receptor Subfamily 1 Group C Member 2 or Peroxisome Proliferator Activated Receptor Beta or NR1C2 or PPARD) - Pipeline Review, H1 2018

Peroxisome Proliferator Activated Receptor Delta (NUCI or Nuclear Hormone Receptor 1 or Nuclear Receptor Subfamily 1 Group C Member 2 or Peroxisome...
颁补迟补濒辞驳:听
Drug Pipeline
Global Markets Direct
Global
January 2018
Price: USD 3,500.00

Hypereosinophilic Syndrome (Hematology) - Drugs in Development, 2021

Hypereosinophilic Syndrome (Hematology) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare...
颁补迟补濒辞驳:听
Drug Pipeline
Global Markets Direct
Global
September 2021
Price: USD 2,000.00

Hypereosinophilic Syndrome - Pipeline Review, H2 2020

Hypereosinophilic Syndrome - Pipeline Review, H2 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline...
颁补迟补濒辞驳:听
Drug Pipeline
Global Markets Direct
Global
November 2020
Price: USD 2,000.00

Hypereosinophilic Syndrome - Pipeline Review, H1 2020

Hypereosinophilic Syndrome - Pipeline Review, H1 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline...
颁补迟补濒辞驳:听
Drug Pipeline
Global Markets Direct
Global
May 2020
Price: USD 2,000.00

Hypertension (Cardiovascular) - Drugs in Development, 2021

Hypertension (Cardiovascular) - Drugs in Development, 2021 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline...
颁补迟补濒辞驳:听
Drug Pipeline
Global Markets Direct
Global
November 2021
Price: USD 2,500.00

Hypereosinophilic Syndrome - Pipeline Review, H2 2019

Hypereosinophilic Syndrome - Pipeline Review, H2 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline...
颁补迟补濒辞驳:听
Drug Pipeline
Global Markets Direct
Global
December 2019
Price: USD 2,000.00

Mild Cognitive Impairment Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Mild Cognitive Impairment Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update Summary Global Markets Direct...
颁补迟补濒辞驳:听
Drug Pipeline
Global Markets Direct
Global
May 2022
Price: USD 2,000.00

Mild Cognitive Impairment - Pipeline Review, H2 2020

Mild Cognitive Impairment - Pipeline Review, H2 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
颁补迟补濒辞驳:听
Drug Pipeline
Global Markets Direct
Global
September 2020
Price: USD 2,000.00

Mild Cognitive Impairment - Pipeline Review, H1 2020

Mild Cognitive Impairment - Pipeline Review, H1 2020 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide...
颁补迟补濒辞驳:听
Drug Pipeline
Global Markets Direct
Global
March 2020
Price: USD 2,000.00

Type 2 Diabetes - Pipeline Review, H2 2019

Type 2 Diabetes - Pipeline Review, H2 2019 Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Type 2...
颁补迟补濒辞驳:听
Drug Pipeline
Global Markets Direct
Global
December 2019
Price: USD 2,500.00

Contact Us for Custom Market Research Solutions

听

Custom Market Research Reports

Clients Who Trust Us

Market Research Reports Inc. Customers

Need tailor made 91制片厂 solution? We can help you with that too.

Contact Us

About Us

At 91制片厂. we aim to make it easier for decision makers to find relevant information and locate right 91制片厂 reports which can save their time and assist in what they do best, i.e. take time-critical decisions.

We work with our associate Global 91制片厂 firms who are known leaders in their respective domains to obtain right 91制片厂 solution for our customer鈥檚 needs, be it custom research or syndicated research reports.

Contact Us

91制片厂
16192 Coastal Hwy
Lewes, DE 19958, USA

USA: +1-302-703-9904

India: +91-8762746600

marketresearchreports

info@marketresearchreports.com

User login

Stay Connected